November 17, 2025 · Form 4 insider transaction
Scott Randal W. sold 6,199 shares of BridgeBio Pharma, Inc. at $66.89 per share, a transaction worth $414.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.; Represents the weighted average sale price of the shares sold from $66.65 to $67.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.